178 related articles for article (PubMed ID: 32332845)
1. The high protein expression of FOXO3, but not that of FOXO1, is associated with markers of good prognosis.
Lallemand F; Vacher S; de Koning L; Petitalot A; Briaux A; Driouch K; Callens C; Schnitzler A; Lecerf C; Oulie-Bard F; Barbet A; Vincent A; Zinn-Justin S; Lopez BS; Lidereau R; Bieche I; Caputo SM
Sci Rep; 2020 Apr; 10(1):6920. PubMed ID: 32332845
[TBL] [Abstract][Full Text] [Related]
2. Evidence for AKT-independent regulation of FOXO1 and FOXO3 in haematopoietic stem and progenitor cells.
Liang R; Rimmelé P; Bigarella CL; Yalcin S; Ghaffari S
Cell Cycle; 2016; 15(6):861-7. PubMed ID: 26929388
[TBL] [Abstract][Full Text] [Related]
3. FoxO proteins or loss of functional p53 maintain stemness of glioblastoma stem cells and survival after ionizing radiation plus PI3K/mTOR inhibition.
Firat E; Niedermann G
Oncotarget; 2016 Aug; 7(34):54883-54896. PubMed ID: 27448972
[TBL] [Abstract][Full Text] [Related]
4. Regulation of glucose uptake and inflammation markers by FOXO1 and FOXO3 in skeletal muscle.
Lundell LS; Massart J; Altıntaş A; Krook A; Zierath JR
Mol Metab; 2019 Feb; 20():79-88. PubMed ID: 30502001
[TBL] [Abstract][Full Text] [Related]
5. Yak FOXO1 and FOXO3 SNPs and association with production traits, and their promotes cells apoptosis via RNAi.
Wang Q; Zhang Q; Wang X; Zhang Y; Zhao X
Gene; 2020 Jun; 743():144592. PubMed ID: 32198125
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma.
Go H; Jang JY; Kim PJ; Kim YG; Nam SJ; Paik JH; Kim TM; Heo DS; Kim CW; Jeon YK
Oncotarget; 2015 Jun; 6(17):15035-49. PubMed ID: 25909227
[TBL] [Abstract][Full Text] [Related]
7. The Transcriptional Regulation of FOXO Genes in Thyrocytes.
Franz F; Weidinger C; Krause K; Gimm O; Dralle H; Führer D
Horm Metab Res; 2016 Sep; 48(9):601-6. PubMed ID: 27258970
[TBL] [Abstract][Full Text] [Related]
8. Regulation of hepatic insulin-like growth factor-binding protein-1 gene expression by insulin: central role for mammalian target of rapamycin independent of forkhead box O proteins.
Mounier C; Dumas V; Posner BI
Endocrinology; 2006 May; 147(5):2383-91. PubMed ID: 16455781
[TBL] [Abstract][Full Text] [Related]
9. FOXO1 functions in the regulation of nicotinamide phosphoribosyltransferase (Nampt) expression.
Jeong B; Park JW; Kim JG; Lee BJ
Biochem Biophys Res Commun; 2019 Apr; 511(2):398-403. PubMed ID: 30799084
[TBL] [Abstract][Full Text] [Related]
10. Integrating bioinformatics and experimental models to investigate the mechanism of the chelidonine-induced mitotic catastrophe via the AKT/FOXO3/FOXM1 axis in breast cancer cells.
Li H; Tang X; Sun Z; Qu Z; Zou X
Biomol Biomed; 2024 May; 24(3):560-574. PubMed ID: 37976368
[TBL] [Abstract][Full Text] [Related]
11. Anti-proliferative activity of disulfiram through regulation of the AKT-FOXO axis: A proteomic study of molecular targets.
Nasrollahzadeh A; Momeny M; Fasehee H; Yaghmaie M; Bashash D; Hassani S; Mousavi SA; Ghaffari SH
Biochim Biophys Acta Mol Cell Res; 2021 Sep; 1868(10):119087. PubMed ID: 34182011
[TBL] [Abstract][Full Text] [Related]
12. NLRC3 regulates cellular proliferation and apoptosis to attenuate the development of colorectal cancer.
Karki R; Malireddi RKS; Zhu Q; Kanneganti TD
Cell Cycle; 2017 Jul; 16(13):1243-1251. PubMed ID: 28598238
[TBL] [Abstract][Full Text] [Related]
13. Goserelin promotes the apoptosis of epithelial ovarian cancer cells by upregulating forkhead box O1 through the PI3K/AKT signaling pathway.
Zhang N; Qiu J; Zheng T; Zhang X; Hua K; Zhang Y
Oncol Rep; 2018 Mar; 39(3):1034-1042. PubMed ID: 29286125
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic Akt-FOXO3 loop favors tumor-promoting modes and enhances oxidative damage-associated hepatocellular carcinogenesis.
Lu M; Hartmann D; Braren R; Gupta A; Wang B; Wang Y; Mogler C; Cheng Z; Wirth T; Friess H; Kleeff J; Hüser N; Sunami Y
BMC Cancer; 2019 Sep; 19(1):887. PubMed ID: 31488102
[TBL] [Abstract][Full Text] [Related]
15. FOXO transcription factors control E2F1 transcriptional specificity and apoptotic function.
Shats I; Gatza ML; Liu B; Angus SP; You L; Nevins JR
Cancer Res; 2013 Oct; 73(19):6056-67. PubMed ID: 23966291
[TBL] [Abstract][Full Text] [Related]
16. FoxO proteins' nuclear retention and BH3-only protein Bim induction evoke mitochondrial dysfunction-mediated apoptosis in berberine-treated HepG2 cells.
Shukla S; Rizvi F; Raisuddin S; Kakkar P
Free Radic Biol Med; 2014 Nov; 76():185-99. PubMed ID: 25128467
[TBL] [Abstract][Full Text] [Related]
17. FOXO3 induces FOXO1-dependent autophagy by activating the AKT1 signaling pathway.
Zhou J; Liao W; Yang J; Ma K; Li X; Wang Y; Wang D; Wang L; Zhang Y; Yin Y; Zhao Y; Zhu WG
Autophagy; 2012 Dec; 8(12):1712-23. PubMed ID: 22931788
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of HepaCAM inhibits bladder cancer cell proliferation and viability through the AKT/FoxO pathway.
Tang M; Zhao Y; Liu N; Chen E; Quan Z; Wu X; Luo C
J Cancer Res Clin Oncol; 2017 May; 143(5):793-805. PubMed ID: 28229220
[TBL] [Abstract][Full Text] [Related]
19. MiRNA-96-5p impacts the progression of breast cancer through targeting FOXO3.
Yin Z; Wang W; Qu G; Wang L; Wang X; Pan Q
Thorac Cancer; 2020 Apr; 11(4):956-963. PubMed ID: 32100957
[TBL] [Abstract][Full Text] [Related]
20. Kinase-driven metabolic signalling as a predictor of response to carboplatin-paclitaxel adjuvant treatment in advanced ovarian cancers.
Sereni MI; Baldelli E; Gambara G; Ravaggi A; Hodge KA; Alberts DS; Guillen-Rodriguez JM; Dong T; Memo M; Odicino F; Angioli R; Liotta LA; Pecorelli SL; Petricoin EF; Pierobon M
Br J Cancer; 2017 Aug; 117(4):494-502. PubMed ID: 28664915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]